Vericel (VCEL) Change in Account Payables (2019 - 2026)
Vericel (VCEL) posted Change in Account Payables of $1.6 million for Q2 2026, down 39.34% sequentially from $2.6 million in Q1 2026, and up 19537.5% YoY from N/an in Q2 2025.
Vericel (VCEL) Change in Account Payables (2019 - 2026) Analysis & Trends
Vericel has reported Change in Account Payables for 8 years, with the latest figure at $1.6 million in Q2 2026.
- Quarterly Change in Account Payables rose 19537.5% year-over-year to $1.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $7.7 million (up 1336.39% YoY) and the FY2025 annual result came in at $3.0 million, up 1136.24% from the prior year.
- Change in Account Payables fell to $1.6 million in Q2 2026 per VCEL's latest filing, from $2.6 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $4.7 million in Q2 2024 and troughed at -$4.9 million in Q1 2024.
- A 5-year average of $629666.7 and a median of $971500.0 in 2023 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2024 and 2026: Change in Account Payables sank 1682.12% in 2024, then soared 19537.5% in 2026.
- Over 5 years, Change in Account Payables stood at $1.5 million in 2022, then soared by 82.43% to $2.7 million in 2023, then plunged by 49.72% to $1.4 million in 2024, then slumped by 47.26% to $713000.0 in 2025, then surged by 120.34% to $1.6 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $1.6 million, $2.6 million, and $713000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Vericel | 2.26 Bn | 2.10 Bn | 56.40 Mn | 1.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.57 Mn |
| Jun 30, 2026 | 1.57 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Mar 31, 2026 | 2.59 Mn |
| Dec 31, 2025 | 713,000.00 |
| Dec 31, 2025 | 713,000.00 |
| Sep 30, 2025 | 2.80 Mn |
| Sep 30, 2025 | 2.80 Mn |
| Jun 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | -551,000.00 |
| Mar 31, 2025 | -551,000.00 |
| Dec 31, 2024 | 1.35 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | 4.67 Mn |
| Jun 30, 2024 | 4.67 Mn |
| Mar 31, 2024 | -4.88 Mn |
| Mar 31, 2024 | -4.88 Mn |